Chemogenetic Activation of Melanopsin Retinal Ganglion Cells Induces Signatures of Arousal and/or Anxiety in Mice  by Milosavljevic, Nina et al.
ReportChemogenetic Activation of Melanopsin Retinal
Ganglion Cells Induces Signatures of Arousal and/or
Anxiety in MiceHighlightsd Chemogenetics is used to recreate a single visual sensation
in dark-housed animals
d mRGC activation alone resets circadian phase and constricts
the pupil
d mRGC activation excites numerous thalamic, hypothalamic,
and limbic brain regions
d mRGC activation realigns behavioral state toward alertness
and/or anxietyMilosavljevic et al., 2016, Current Biology 26, 2358–2363
September 12, 2016 ª 2016 The Authors. Published by Elsevier
http://dx.doi.org/10.1016/j.cub.2016.06.057Authors
Nina Milosavljevic,
Jasmina Cehajic-Kapetanovic,
Christopher A. Procyk, Robert J. Lucas
Correspondence
nina.milosavljevic@manchester.ac.uk
In Brief
Milosavljevic et al. use chemogenetics to
recreate the sensation of bright
background light in mice held in
darkness. This selective modulation
resets the circadian clock; activates
thalamic, hypothalamic, and limbic nuclei
controlling diverse aspects of behavior
and physiology; and induces a behavioral
state of increased alertness and/or
anxiety.Ltd.
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Functional imaging and psychometric assessments
indicate that bright light can enhance mood,
attention, and cognitive performance in humans.
Indirect evidence links these events to light detec-
tion by intrinsically photosensitive melanopsin-
expressing retinal ganglion cells (mRGCs) [1–9].
However, there is currently no direct demonstra-
tion that mRGCs can have such an immediate
effect on mood or behavioral state in any species.
We addressed this deficit by using chemogenetics
to selectively activate mRGCs, simulating the
excitatory effects of bright light on this cell
type in dark-housed mice. This specific manipula-
tion evoked circadian phase resetting and pupil
constriction (known consequences of mRGC acti-
vation). It also induced c-Fos (a marker of neuronal
activation) in multiple nuclei in the hypothalamus
(paraventricular, dorsomedial, and lateral hypo-
thalamus), thalamus (paraventricular and centro-
median thalamus), and limbic system (amygdala
and nucleus accumbens). These regions influence
numerous aspects of autonomic and neuroendo-
crine activity and are typically active during
periods of wakefulness or arousal. By contrast,
c-Fos was absent from the ventrolateral preoptic
area (active during sleep). In standard behavioral
tests (open field and elevated plus maze), mRGC
activation induced behaviors commonly inter-
preted as anxiety like or as signs of increased
alertness. Similar changes in behavior could be
induced by bright light in wild-type and rodless
and coneless mice, but not melanopsin knockout
mice. These data demonstrate that mRGCs drive
a light-dependent switch in behavioral motivation
toward a more alert, risk-averse state. They also
highlight the ability of this small fraction of retinal
ganglion cells to realign activity in brain regions
defining widespread aspects of physiology and
behavior.2358 Current Biology 26, 2358–2363, September 12, 2016 ª 2016 Th
This is an open access article under the CC BY license (http://creativeRESULTS AND DISCUSSION
Determining whether melanopsin-expressing retinal ganglion
cells (mRGCs) control behavioral state is complicated by the
fact that their natural stimulus (bright background light) also
allows numerous other visual responses to be engaged. One
solution is to study mice lacking rods and cones, in which mela-
nopsin (and therefore mRGCs) provides the only visual signal
[10]. However, such preparations have substantial retinal reorga-
nization [11], making them an imperfect representation of the
intact system. Here, we therefore developed amethod of acutely
and selectively activating mRGCs in darkness in animals with a
fully intact retina. Our approach was to target expression of the
Gq-coupled chemogenetic tool hM3Dq (which reliably induces
depolarization of neurons after administration of clozapine
N-oxide [CNO] [12]) to mRGCs. Application of CNO should
then mimic the excitatory effect of light for mRGCs without pro-
ducing any other visual experience. To this end, we injected an
AAV2 vector carrying a FLEX-switched hM3Dq coding sequence
into the vitreous of Opn4Cre/+ mice. Selective expression of
hM3Dq in mRGCs was confirmed in retinal whole mounts (Fig-
ures 1A and S1A) and sections (Figures 1B and S1B). Across
nine retinas, 35% ± 7.5% (mean ± SD) of mRGCs expressed
hM3Dq (mCherry marker), whereas all 722 hM3Dq-expressing
cells detected were mRGCs (GFP marker). The distribution of
soma size and projection pattern of transduced cells (Figure S1)
was similar to that of the total mRGC population [8, 13], implying
that there was no strong bias in transduction efficiency between
subtypes of mRGC.
To confirm that the expressed receptor was able to simulate
the effects of light exposure for mRGC driven responses, we
asked whether CNO induced pupil constriction and circadian
phase shifts (both established mRGC endpoints) in animals
kept in darkness. Intraperitoneal injection of CNO (5 mg/kg) in
mice unilaterally expressing hM3Dq induced strong bilateral pu-
pil constriction within 20 min of application and persisting for at
least 120 min (Figure 1C; 90% constriction, equivalent to the
effect of 1016 photons/cm2/s; Figures S2A–S2D). To assess ef-
fects on the circadian clock, we recorded wheel-running
behavior from animals free running in constant darkness and
presented with 0.25 mg/mL CNO in sweetened drinking water
(0.2% saccharine and 4% sucrose) for 2 hr at circadian time
14 (CT14). Mice drank between 650 and 800 mL (mean ± SD:
750 ± 58 mL and 700 ± 89 mL for hM3Dq and control,e Authors. Published by Elsevier Ltd.
commons.org/licenses/by/4.0/).
Figure 1. Chemogenetic Activation of
mRGCs
(A and B) After intravitreal injection of a viral vector
(AAV2-hSyn-DIO-hM3Dq-mCherry) to Opn4Cre:Z/
EGFP mice, immunohistochemical staining re-
vealed transgene (mCherry; red) expression in
GFP-positive neurons (green) in an en face view of
retinal whole mounts (A) and retinal section (B).
The retinal section shows the expression of
transgene in cells of the retinal ganglion and inner
nuclear cell layers (GCL and INL) of hM3Dq
Opn4Cre/+ mice. Notice the different soma sizes of
transduced cells (arrows), with DAPI stain in blue.
A monochrome version of mCherry staining and
more details on hM3Dq expression are provided in
Figure S1.
(C) Representative images of eyes under infrared
illumination from hM3Dq-expressing mice held
in darkness, prior to (top) and at 20, 120, and
180 min after intraperitoneal (i.p.) injection of CNO
(5 mg/kg). For more details, see Figure S2.
(D) Representative double-plotted actogram of
wheel running activity of a hM3Dq mouse housed
under a light:dark cycle (the light phase is indi-
cated in yellow) until day 12 followed by constant
darkness. The star shows the start of a 2 hr pre-
sentation of 0.25 mg/mL CNO in drinking water;
the red line to left represents the eye fit through
activity onsets. A representative double-plotted
actogram of a control mouse is shown in Fig-
ure S3.
(E) Change in circadian phase CNO application to
hM3Dq-expressing (open bars; n = 4) and control
(filled bars; n = 5) mice (means ± SEM; Mann-
Whitney U test, p = 0.015).
(F) Representative micrographs of coronal section
through the SCN labeled for c-Fos (dark) from
hM3Dq and control mice after CNO administration
(5 mg/kg, i.p., at CT14).
(G) Mean (±SEM) number of c-Fos positive cells
mm2 in SCN sections from hM3Dq (n = 6)
and control (n = 6) mice (two-tailed unpaired
t test,**p < 0.01).respectively), corresponding to 5–6.25mg/kg of CNO. This treat-
ment had the same effect as a bright light pulse at this time of
night [14], delaying the circadian rhythm by 107 ± 30min (Figures
1D and 1E). Neither of these effects of CNO administration con-
stricted the pupil or shifted the clock in control mice lacking
hM3Dq expression (Figures 1E, S2B, and S2E).
We next used induction of the immediate early gene, c-Fos, to
identify brain regions excited by mRGC activation. In mice with
unilateral hM3Dq expression, CNO injection (at CT14) induced
strong bilateral c-Fos expression in the suprachiasmatic nuclei
(SCN; the site of the master circadian clock and major hypotha-
lamic target of mRGCs; Figures 1F and 1G). Elsewhere in the hy-
pothalamus, we found significant bilateral c-Fos induction in the
paraventricular hypothalamic nucleus (PVN), dorsomedial hypo-
thalamus/dorsal hypothalamic area (DMH/DHA), and lateral
hypothalamic area (LH) (Figures 2A and 2C). Together, these re-
gions have access to very wide-ranging aspects of physiology
and behavior. The PVN is one of the most important hypotha-lamic control centers, containing neuroendocrine neurons
fundamental for hormonal regulation and homeostasis (hypo-
thalmic-pituitary -adrenal [HPA] and -thyroid [HPT] axis, vaso-
pressin, and oxytocin) and autonomic neurons connected to
parasympathetic and sympathetic centers in brainstem and spi-
nal cord. The DMH/DHA is also implicated in corticosteroid
secretion and thermoregulation and, together with the LH, in
controlling locomotor activity and feeding [15–19]. As a group
(PVN, DMH/DHA, and LH), they are excited during periods of
wakefulness [15, 20]. Accordingly, despite receiving a sparse
mRGC projection, we found no significant c-Fos induction in
the sleep activating ventrolateral preoptic area (VLPO) (Fig-
ure 2C) [8].
Turning to regions outside of the hypothalamus, we explored
the amygdala, as this has been reported to be light activated in
humans [7] and also to receive inputs frommRGCs [8].We indeed
found enhanced bilateral c-Fos in both basolateral (BLA) and
central (CeA) amygdala (Figures 2B and 2C). Within the thalamusCurrent Biology 26, 2358–2363, September 12, 2016 2359
Figure 2. c-Fos Activity Mapping after Che-
mogenetic Activation of mRGCs
(A and B) Representative micrographs of coronal
sections showing c-Fos labeling (dark) in (A) the
paraventrical hypothalamic nucleus (PVN), the
dorsomedial hypothalamus/dorsal hypothalamic
area (DMH/DHA), lateral (perifornical) hypotha-
lamic area (LH), and ventrolateral preoptic nucleus
(VLPO); and (B) amygdala (Amg), intralaminar
thalamic nuclei (ITL), paraventricular thalamus
(PVT), lateral habenula (LHb), and nucleus ac-
cumbens (NAc). Images to right of each panel are
from control mice, and those to left are from uni-
lateral hM3Dq-expressing animals (transduced
eye to right of presented image, except in LH,
VLPO, Amg, and NAc, where only the contralateral
region is shown).
(C) Mean (±SEM) number of c-Fos-positive cells
mm2 in all brain regions (bilaterally) after CNO
administration (5 mg/kg, i.p., at CT14) in hM3Dq-
expressing (open bars; n = 8) and control (filled
bars; n = 8) mice (two-tailed unpaired t test,
*p < 0.05, **p < 0.01, ***p < 0.001). A complete
summary of c-Fos data is provided in Table S1.
BLA, basolateral amygdala; CeA, central nucleus
of the amygdala.
(D) Brain diagram illustrating target areas analyzed.(and leaving aside conventional visual areas), c-Fos induction
was restricted to theparaventricular thalamic (PVT) and intralami-
nar thalamic nuclei (ILT) (Figures 2B and 2C). Both the PVT and
ILT have been independently associated with enhanced alert-
ness and vigilance [21, 22], and the PVT plays a key role in energy
homeostasis, arousal, temperature modulation, endocrine regu-
lation, and reward [23]. The centromedian nucleus, a part of the
ILT, receives a sparse input from mRGCs [9].
Previous work with chronically disrupted light exposure has
revealed a depressive state in mice associated with activation
of the lateral habenula [24]. We wondered whether acute activa-
tion of mRGCs had a similar effect. In fact, we did not find signif-
icant c-Fos induction in the lateral habenula (Figures 2B and 2C).
Conversely, c-Fos was enhanced in the nucleus accumbens,
a region typically associated with enhanced motivation and
reward-seeking behavior [25].2360 Current Biology 26, 2358–2363, September 12, 2016In order to test whether these neuro-
physiological events translate to a change
in behavioral state, we next tested the
impact of selective mRGC activation on
a battery of behavioral tests under dim
far-red light (2.91 mW cm2, l > 680 nm).
The open field test (OFT) is based on nat-
ural exploratory behavior of rodents in a
novel open arenaandwidely used tomea-
sure mood changes in rodents. Anxiety-
like behavioral states are associated
with a reduced fraction of time spent in
the center of the arena, an outcome that
is independent of changes in total activity
[26–28]. It has previously been reported
that bright light induces such a responsein rats [29].We testedCNO-treatedmicewith bilateral expression
of hM3Dq in mRGCs and found that they spent significantly less
time in the center than controls (Figure 3A), although their overall
activity was unaffected (total distance traveled, mean ± SEM: for
control mice, 3,082 ± 245 cm and 3,369 ± 272 cm; for hM3Dq
mice, 3,843 ± 260 cm and 3,384 ± 275 cm; saline and CNO,
respectively; p > 0.05, two-way ANOVA).
For an independent assessment of mRGC-induced mood
changes, we turned to an elevated plus maze (EPM), in which
risk-averse states are reflected in avoidance of open arms.
Again, hM3Dq-expressing mice treated with CNO entered
open arms less frequently and spent less time in open arms
than did controls (Figures 3B and 3C). There was a suggestion
that they entered closed arms less frequently, indicating an over-
all reduction in activity, but this difference was not significant
against all controls (Figure 3D).
Figure 3. Chemogenetic and Light Activa-
tion of mRGCs Alters Performance in
Behavioral Tests
(A) Time spent in center over 10 min under dim far-
red illumination in an open arena in hM3Dq-
expressing and control Opn4Cre/+ mice treated
with CNO or saline. Open bars depict data from
hM3Dq-expressing mice, and filled bars depict
data from control Opn4Cre/+ mice.
(B–D) Time spent in open arms (B) and the number
of entries to open (C) and closed (D) arms of an
elevated plus maze under dim far-red illumination
in hM3Dq and control Opn4Cre/+ mice treated with
CNO or saline.
(E) Time spent by visually intact (Opn4Cre/+) and
rodless and coneless (rd1;Cnga3/) mice in
center of an open arena under bright or dim far-red
light.
(F) Time spent by visually intact (Opn4Cre/+)
and melanopsin knockout (Opn4/) mice in cen-
ter of an open arena under bright or dim far-red
light.
All behavioral tests undertaken between CT14
and CT17; n = 9–13 per group, two-way ANOVA
with post hoc Bonferroni correction, *p < 0.05,
**p < 0.01. All graphs depict mean ± SEM, with
open bars depicting hM3Dq-expressing mice and
closed bars depicting control Opn4Cre/+ mice,
except in (E) and (F), where closed bars depict
dim light and hatched bars depict bright light.
In all cases, dim far-red light was 2.91 mW cm2,
l > 680 nm, and bright light was white,
217 mW cm2.Chronic disruption of light:dark cycles has been reported to
induce a depressive state in mice [24]. However, CNO-treated
hM3Dq-expressing mice showed no increased tendency toward
helplessness (immobility) when subjected to a forced swim test
(mean ± SEM, percentage time immobile: for control mice,
64.0% ± 10% and 56.3% ± 7.8%; for hM3Dq-expressing mice
46.5% ± 5.9% and 40.3% ± 6.1%; saline and CNO treatments,
respectively; p > 0.05, two-way ANOVA). This argues that the im-
mediate effects of mRGC activation do not extend to inducing a
depressive state and that the published work in this area instead
relates to the effects of chronic aberrant light exposure.
Collectively, these data reveal that selective activation of
mRGCs has immediate effects on diverse brain structures and
changes behavioral state. The range of brain regions showing
c-fos induction after CNO administration in our hM3Dq-express-
ing mice is consistent with those implicated in changing mood
and attention in humans based upon neuroimaging studies.
The multiple functions of the sub-cortical structures involved
allow the possibility that numerous behavioral and neuroendo-
crine systems may be engaged by this signal.
The overall effect of chemogenetic activation of mRGCs on
behavioral state seems to be an increase in alertness and/or anx-
iety. The behavioral changes in OFT and EPM tests are consid-
ered indicators of enhanced risk aversion and commonly defined
as anxiety like. However, as autonomic activation and increased
arousal are among the earliest events observed in a state of anx-iety, they could also be interpreted as increased attention
or alertness [30]. Moreover, the chemogenetic manipulation
induced c-Fos not in the sleep-active VLPO, but rather in the
DMH/DHA (known to provide inhibitory control of the VLPO
[16]), and in a range of other regions typically thought to be active
during wakefulness (DMH/DHA, LH, and PVN) and arousal
(amygdala, PVT, and ILT).
Thus, our c-fos and behavioral data both indicate an increase
in anxiety and/or arousal after mRGC activation. However, previ-
ous studies have suggested that bright light has the opposite ef-
fect of inducing sleep [31, 32, 33]. To resolve this apparent
contradiction, we finally tested the response of mice to bright
light when challenged with the open field test. We found that in
the light, wild-type (Opn4Cre/+, visually intact) mice showed the
same reduction in time in the center previously observed for
CNO-treated hM3Dq-expressing mice (Figures 3E and 3F; total
distance traveled, mean ± SEM: 1,669 ± 178 cm and 3,082 ±
245 cm in the bright and dim far-red light, respectively). This anx-
iogenic effect of light was recapitulated in rodless and coneless
mice (rd1;Cnga3/; Figure 3E; total distance traveled, mean ±
SEM: 2,000 ± 225 cm and 3,229 ± 271 cm in the bright and
dim far-red light, respectively) but was absent in mice lacking
melanopsin (Opn4/; Figure 3F; total distance traveled,
mean ± SEM: 3,286 ± 357 cm and 4,728 ± 585 cm in light
and dark, respectively). The latter data are similar to those
from a very recent study comparing responses to ‘‘blue’’ lightCurrent Biology 26, 2358–2363, September 12, 2016 2361
in wild-type and melanopsin knockout mice [34].Together, they
confirm that light can have arousal and/or anxiogenic effects
and that mRGCs are both sufficient and necessary for this
response. The ethological significance of such divergent light
responses is unclear, but the observation that the appropriate
response to a sensory stimulus may be context dependent is
not in itself surprising. An arousal response would have an
obvious survival advantage in mice for whom exposure to bright
light would invariably indicate a situation of heightened danger.
More importantly, it indicates that under the right circum-
stances, mRGCs can drive a change in mouse behavioral state
analogous to the increase in alertness and arousal experienced
by humans.
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